Loading data
CSTMNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 8.45 bn USD | 7.34 bn USD | 7.83 bn USD | 8.53 bn USD |
| Research and development expense | 51 m USD | 49 m USD | 52 m USD | 46 m USD |
| Selling, general and administrative expense | 332 m USD | 313 m USD | 317 m USD | 284 m USD |
| Profit before tax | 408 m USD | 135 m USD | 232 m USD | 150 m USD |
| Income tax expense | 133 m USD | 75 m USD | 75 m USD | -165 m USD |
| Net income (reported basis) | 275 m USD | 60 m USD | 157 m USD | 315 USD |
| Basic earnings per share | 1.95 USD/share | 0.38 USD/share | 1.04 USD/share | 2.14 USD/share |
| Diluted earnings per share | 1.92 USD/share | 0.38 USD/share | 1.03 USD/share | 2.1 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.